# ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors

> clinical trial · VERIFIED · 2026-06-11

Status: RECRUITING · Sponsor: Sabine Mueller, MD, PhD · Condition: Diffuse Midline Glioma (DMG)

- Company: Sabine Mueller, MD, PhD
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT04732065

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED.